Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | PTPRC | P08575 | 1/20 | 0.48 |
| ▸ | S100A4 | P26447 | 1/20 | 0.48 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.45 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.45 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10638495 | 0.84 | PTPRC (0.57) | LMNAMEN1HTTKMT2ATSHR | |
| SCHEMBL790761 | 0.82 | TDP1 (0.61) | LMNAMEN1HTTKMT2ATSHR | |
| SCHEMBL3836830 | 0.82 | TDP1 (0.61) | LMNAMEN1HTTKMT2ATSHR | |
| SCHEMBL2569715 | 0.82 | GPR35 (0.59) | LMNAMEN1HTTKMT2ATSHR | |
| SCHEMBL30414747 | 0.82 | TDP1 (0.61) | LMNAMEN1HTTKMT2ATSHR | |
| SCHEMBL23779897 | 0.80 | ALDH1A1 (0.62) | LMNAMEN1HTTKMT2ATSHR | |
| SCHEMBL482237 | 0.80 | TSHR (0.62) | LMNAMEN1HTTKMT2ATSHR | |
| SCHEMBL16959133 | 0.80 | TSHR (0.46) | LMNAMEN1HTTKMT2ATSHR | |
| SCHEMBL15201566 | 0.80 | ALDH1A1 (0.47) | LMNAMEN1HTTKMT2ATSHR | |
| SCHEMBL527700 | 0.80 | ALDH1A1 (0.67) | LMNAMEN1HTTKMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10280304-B2 | Polyarylene sulfide resin composition | TEIJIN LIMITED (JP) | 2019-05-07 | — | — | US | disclosed |
| US-10233327-B2 | Polyarylene sulfide resin composition | TEIJIN LIMITED (JP) | 2019-03-19 | — | — | US | disclosed |
| EP-3103841-B1 | POLYARYLENE SULFIDE RESIN COMPOSITION | TEIJIN LTD (JP) | 2018-09-26 | — | — | EP | disclosed |
| US-20180215918-A1 | POLYARYLENE SULFIDE RESIN COMPOSITION | TEIJIN LIMITED (JP) | 2018-08-02 | — | — | US | disclosed |
| US-20160376439-A1 | POLYARYLENE SULFIDE RESIN COMPOSITION | TEIJIN LIMITED (JP) | 2016-12-29 | — | — | US | disclosed |
| EP-3103841-A1 | POLYARYLENE SULFIDE RESIN COMPOSITION | Teijin Limited (JP) | 2016-12-14 | — | — | EP | disclosed |
| CN-105980480-A | POLYARYLENE SULFIDE RESIN COMPOSITION | 帝人株式会社 | 2016-09-28 | — | — | CN | disclosed |
| US-9067900-B2 | Diaminophenothiazine compounds, a method for preparing same and uses thereof | PHARMA HYDRO DEVELOPMENT—P.H.D. (FR) | 2015-06-30 | — | — | US | disclosed |
| US-8957182-B2 | Polyarylene sulfide resin with excellent luminosity and preparation method thereof | SK CHEMICALS CO., LTD. (KR) | 2015-02-17 | — | — | US | disclosed |
| CN-104039149-A | Boron-containing small molecules | ANACOR PHARMACEUTICALS INC | 2014-09-10 | — | — | CN | disclosed |
| US-20140194592-A1 | POLYARYLENE SULFIDE RESIN WITH EXCELLENT LUMINOSITY AND PREPARATION METHOD THEREOF | SK CHEMICALS CO., LTD. (KR) | 2014-07-10 | — | — | US | disclosed |
| CN-101472585-B | Antibacterial compositions | BIOTA EUROPE LTD | 2013-12-04 | — | — | CN | disclosed |
| EP-2185531-B1 | Diaminophenothiazine compounds, a method for preparing same and uses thereof | PHARMA HYDRO DEV P H D (FR) | 2012-07-25 | — | — | EP | disclosed |
| US-20100204215-A1 | NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF | PHARMA HYDRO DEVELOPMENT - P.H.D. (FR) | 2010-08-12 | — | — | US | disclosed |
| EP-2185531-A2 | NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF | Pharma Hydro Development - P.H.D. (FR) | 2010-05-19 | — | — | EP | disclosed |
| WO-2009044054-A2 | NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF | PHARMA HYDRO DEVELOPMENT - P.H.D. (FR) | 2009-04-09 | — | — | WO | disclosed |
| EP-1984332-A2 | METHODS FOR TREATING HEPATITIS C | PTC Therapeutics, Inc. (US) | 2008-10-29 | — | — | EP | disclosed |
| WO-2007084413-A2 | METHODS FOR TREATING HEPATITIS C | PTC THERAPEUTICS, INC. (US) | 2007-07-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204215-A1 | NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF | AOC1, DDT, DDC | LMNA 4600/4885MEN1 2765/4885HTT 2225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.